Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ARL4C |
| Upstream (Parents) |
|---|
| (<<) ADCY6 → ARL4C |
| (<<) AVP → ARL4C |
| (<<) BCL2 → ARL4C |
| (<<) DLX2 → ARL4C |
| (<<) EN2 → ARL4C |
| (<<) FGF7 → ARL4C |
| (<<) FZD9 → ARL4C |
| (<<) IDI1 → ARL4C |
| (<<) KCNG1 → ARL4C |
| (<<) PAK2 → ARL4C |
| (<<) PSORS1C2 → ARL4C |
| (<<) PTPN11 → ARL4C |
| (<<) ROCK1 → ARL4C |
| (<<) SERPINB2 → ARL4C |
| (<<) SLC26A1 → ARL4C |
| Downstream (Children) |
|---|
| ARL4C → GRIN1 (>>) |
| ARL4C → HCN2 (>>) |
| ARL4C → MYH14 (>>) |
| ARL4C → SPRR2C (>>) |
